FBP1 and osteosarcoma: Mechanistically, TRIM47 reduced the protein stability of fructose 1, 6‐bisphosphatase 1 (FBP1), thereby triggering the activation of the Wnt/β‐catenin pathway, ultimately leading to tumorigenesis and progression of osteosarcoma.